ClinVar Miner

Submissions for variant NM_001370259.2(MEN1):c.1170G>A (p.Pro390=)

gnomAD frequency: 0.00003  dbSNP: rs587780841
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000199870 SCV000252882 benign Multiple endocrine neoplasia, type 1 2025-02-02 criteria provided, single submitter clinical testing
Ambry Genetics RCV000569118 SCV000673627 likely benign Hereditary cancer-predisposing syndrome 2015-09-25 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Counsyl RCV000199870 SCV000785190 likely benign Multiple endocrine neoplasia, type 1 2017-05-25 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000729820 SCV000857511 likely benign not specified 2017-10-12 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000199870 SCV001156565 benign Multiple endocrine neoplasia, type 1 2018-08-15 criteria provided, single submitter clinical testing
GeneDx RCV001706182 SCV001865641 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000569118 SCV002530045 benign Hereditary cancer-predisposing syndrome 2021-12-29 criteria provided, single submitter curation
Myriad Genetics, Inc. RCV000199870 SCV004018034 benign Multiple endocrine neoplasia, type 1 2023-04-17 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000729820 SCV004220024 benign not specified 2022-06-09 criteria provided, single submitter clinical testing The frequency of this variant in the general population (http://gnomad.broadinstitute.org) is higher than would generally be expected for pathogenic variants in this gene. Computational tools yielded predictions that this variant is unlikely to have an effect on normal RNA splicing. This nucleotide position exhibits low evolutionary conservation.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000729820 SCV004241733 benign not specified 2023-12-27 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000199870 SCV004359146 likely benign Multiple endocrine neoplasia, type 1 2022-11-06 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV000199870 SCV004821467 likely benign Multiple endocrine neoplasia, type 1 2024-01-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.